RXST earnings date and last-quarter result: last quarter beat, P/E -4.77. Updated 2026-07-23.
RxSight (RXST) Research Hub
RxSight (RXST) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 4.93 USD (-1.79%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.77, market cap 0.22B. This hub links to the full technical, earnings and options research available for RXST.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.93 USD (-1.79%) |
| 52-week range | 4.4 USD – 7.44 USD |
| Trend regime | Range |
| 14-day RSI | 59 (Bullish) |
| Trailing P/E | -4.77 |
| Market cap | 0.22B |
| Dividend yield | 0.00% |
Available research for RXST
Covered Call on RXST: how it works, illustrative setup around the real 4.93 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on RXST: how it works, illustrative setup around the real 4.93 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on RXST: how it works, illustrative setup around the real 4.93 USD price, max profit/loss, breakeven and when to use it. Educational.
RXST technical analysis: range, last 4.93 USD, RSI 59, 52w range 4.4 USD–7.44 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is RXST in?
RxSight (RXST) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is RXST in an uptrend or downtrend?
As of 2026-10-26, RXST is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is RXST's trailing P/E ratio?
RXST's trailing P/E is -4.77, with a market cap of 0.22B. See the earnings research page for full valuation detail.